Search

Your search keyword '"Karras, A"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Karras, A" Remove constraint Author: "Karras, A" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
244 results on '"Karras, A"'

Search Results

5. Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma

7. International consensus on fasting terminology

9. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma

11. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

12. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms

14. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells

15. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features

17. The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies

19. HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

23. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

24. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

27. Glomerular diseases in pregnancy: pragmatic recommendations for clinical management

32. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy

34. Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy

35. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series

36. Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

38. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

40. Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

41. ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification

42. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

45. Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

49. Rituximab in Membranous Nephropathy

50. Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry

Catalog

Books, media, physical & digital resources